Shahrukh Bengali, MD
Anesthesiology · Gainesville, FLNPI 1992267470
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (43.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 36.2% of the total. Reporting peaked in 2023 at $7,438 and has fallen 51.2% since, to $3,628 in 2025. Among anesthesiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $142.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Abbott$3K
- Medtronic$3K
- Saluda Medical Americas, Inc.$2K
- Spinal Simplicity, LLC$1K
- Collegium Pharmaceutical, Inc.$291
- plus $539 from 13 others
What the payments were for
- Grants$6,78044%
- Travel & lodging$5,37235%
- Food & beverage$3,40622%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $5,634 |
| Abbott | 3 | $3,063 |
| Medtronic | 36 | $2,866 |
| Saluda Medical Americas, Inc. | 7 | $2,072 |
| Spinal Simplicity, LLC | 11 | $1,093 |
| Collegium Pharmaceutical, Inc. | 18 | $291 |
| Nevro Corp. | 4 | $131 |
| Curonix LLC | 1 | $115 |
| Pfizer | 3 | $56 |
| Globus Medical | 2 | $45 |
| SPR Therapeutics, Inc | 2 | $37 |
| AbbVie | 2 | $36 |
| Tersera Therapeutics LLC | 1 | $22 |
| Foundation Fusion Solutions, LLC | 1 | $20 |
| IBSA Pharma Inc. | 1 | $17 |
| Vertex | 1 | $16 |
| Painteq LLC | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,558 in reported general payments places this provider in the 95th percentile of 2,767 anesthesiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 12 | $6,815 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 115 | $3,186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 115 | $3,066 |
| Pregabalin | 79 | $1,710 |
| Lidocaine | 17 | $1,457 |
| Tramadol Hcl | 88 | $966 |
| Gabapentin | 72 | $931 |
| Morphine Sulfate ErMorphine Sulfate | 26 | $825 |
| Duloxetine Hcl | 53 | $771 |
| Oxycodone Hcl | 58 | $731 |
| Tizanidine Hcl | 51 | $426 |
| Methadone Hcl | 15 | $419 |
| Cyclobenzaprine Hcl | 30 | $374 |
| Methocarbamol | 20 | $339 |
| Morphine Sulfate | 13 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $291 | $6,81512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,767 anesthesiology providers in Florida.
Other anesthesiology in Gainesville
- Andre BoezaartGainesville$119K
- Jackson WagonerGainesville$70K
- Felipe UrdanetaGainesville$48K
- Thorsten HaasGainesville$42K
- Lauren BerkowGainesville$38K
- Marc MaybauerGainesville$38K
- Bruce SpiessGainesville$34K
- Nikolaus GravensteinGainesville$32K
- Amir JafariGainesville$15K
- David HutchinsonGainesville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.